🇨🇦 CHF5993 in Canada

CHF5993 (CHF5993) regulatory status in Canada.

Marketing authorisation

CHF5993 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Canada

Frequently asked questions

Is CHF5993 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for CHF5993 in Canada?

Chiesi Farmaceutici S.p.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.